Rational approach for immunotherapy in ovarian cancer. KU Leuven
The goal of this project is to convince pharma industry ot incorporate an immune read out in future immunotherapy trials, to take the first steps towards biomarker validation using immune cells and ht initiate a clinical immunotherapy trial based on the best availalble preclinical evidence. If we succeed, this will result in a better survival, tailoring of the correct therapy to the correct patients at the correct moment, it will lead to a ...